A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
Condition(s):House Dust Mite AllergyLast Updated:January 30, 2017Completed
Hide Studies Not Open or Pending
Condition(s):House Dust Mite AllergyLast Updated:January 30, 2017Completed
Condition(s):House Dust Mite AllergyLast Updated:February 8, 2023Recruiting
Condition(s):House Dust Mite AllergyLast Updated:July 8, 2022Not yet recruiting
Condition(s):House Dust Mite AllergyLast Updated:March 29, 2017Completed
Condition(s):House Dust Mite AllergyLast Updated:December 2, 2015Completed
Condition(s):House Dust Mite AllergyLast Updated:February 11, 2013Completed
Condition(s):House Dust Mite Allergy; RhinoconjunctivitisLast Updated:May 15, 2014Completed
Condition(s):Rhinoconjunctivitis; AllergiesLast Updated:November 15, 2010Completed
Condition(s):House Dust Mite AllergyLast Updated:December 3, 2015Terminated
Condition(s):Perennial Allergic Rhinoconjunctivitis; House Dust Mite AllergyLast Updated:July 11, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.